Caricamento...

Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Crespo, Carlos, Moreno, Estela, Sierra, Jordi, Serip, Suzan, Rubio, Marta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029489/
https://ncbi.nlm.nih.gov/pubmed/24314138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-28
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !